UnknownNot Applicable

The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics

Turkey (Türkiye)42 participantsStarted 2021-03-01

Plain-language summary

The aim of this study is to determine the effect of the treatment of polycystic ovary syndrome with two different oral contraceptives that contain cyproterone acetate and drospirenone

Who can participate

Age range15 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who are diagnosed with polycystic ovary syndrome according to Rotterdam criteria and who do not have any additional chronic systemic disease Exclusion Criteria: * The presence of any diseases that cause hormonal disorders and any chronic systemic diseases, the patients who are already under any treatment for polycystic ovary syndrome

What they're measuring

Metabolomics

Timeframe: 3 months

Trial details

NCT IDNCT04831151

SponsorInonu University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03

Contact for this trial

Senem Arda Düz, Asisstant professor

+905332776401 senem_arda@yahoo.com

View on ClinicalTrials.gov More Polycystic Ovary Syndrome trials